Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: A Non-interventional, Prospective Study With Benralizumab

View source ↗

Summary

This document describes a non-interventional, prospective study evaluating benralizumab for asthma, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Bronchial | Status: RECRUITING